Kevin Davies PhD

Kevin Davies has more than three decades of experience in science publishing as an editor, journalist, author and publisher. He is the founding editor of Nature Genetics and Bio-IT World magazine and also served as Editor-in-Chief of Cell Press and publisher of Chemical & Engineering News. He joined the GEN team in 2017 and was promoted to Editorial Director in 2023. In addition to working with GEN, Kevin spearheaded the launch in 2018 of The CRISPR Journal. In 2022, he led the launch of GEN Biotechnology, the new marquee peer-review journal that bears the GEN logo.

Kevin is the author (or co-author) of five popular science books including Cracking the Genome, The $1,000 Genome, and an updated version of DNA: The Story of the Genetic Revolution (with James D. Watson and Andrew Berry). In 2017, Kevin won a Guggenheim fellowship in science writing to support a new book, Editing Humanity: The CRISPR Revolution and the New Era of Genome Editing, published in September 2020.

Kevin holds a degree in Biochemistry from Oxford University and a PhD in Human Genetics from St Mary’s Hospital Medical School, London. He held postdoctoral fellowships at MIT and Harvard Medical School before joining the editorial staff at Nature. He is based in Washington DC and still clings to a British accent.